Advances in the Treatment of Autosomal Dominant Polycystic Kidney Disease and Novel Therapeutic Targets. [PDF]
Curr Issues Mol BiolZhang W, Sun T, Wang X, Jiang T.
europepmc +1 more source
Epithelial plasma membrane transporters as drug targets. [PDF]
Physiol RevVerkman AS.
europepmc +1 more source
Carrier-free procyanidin-ferric nanonetworks loading gefitinib to inhibit TMEM16A-EGFR mutual activation loop for photothermally enhanced breast cancer targeted therapy. [PDF]
Mater Today BioLi G +10 more
europepmc +1 more source
Isolation and long-term culture of primary mouse cholangiocytes that retain biophysical properties and distinct Cl-conductances: An initial study. [PDF]
Physiol RepLi Q +4 more
europepmc +1 more source
Research progress on TMEM proteins in cancer progression and chemoresistance (Review). [PDF]
Int J Mol MedShi J +5 more
europepmc +1 more source
The pharmacology and cardiovascular function of TMEM16A channels
, 2015 Calcium-activated chloride channels (CaCCs) are ubiquitously expressed in a plethora of cell types and, consequently, are involved in numerous cellular processes as diverse as epithelial secretion, regulation of cardiac excitability and smooth muscle contraction.
openaire +1 more source
TMEM16A in prostate cancer: mechanistic insights and therapeutic implications. [PDF]
Cancer Cell IntHe JW, Li PZ, Huang ZX.
europepmc +1 more source
Dihydrosanguinarine: A Review of Its Pharmacology, Structure-Activity Relationship, Toxicity, Pharmacokinetics, and Clinical Prospects. [PDF]
Int J Mol SciYin X +7 more
europepmc +1 more source
Afatinib amplifies cAMP-induced fluid secretion in a mouse mini-gut model via TMEM16A-mediated fluid secretion and secretory cell differentiation. [PDF]
Sci RepAriyadamrongkwan J +3 more
europepmc +1 more source
[Transmembrane protein 16A--a new target for the treatment of airway inflammatory diseases]. [PDF]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za ZhiLuo Q, Xu N, Tan X.
europepmc +1 more source